Guided by UMB’s core values, the Office of Accountability and Compliance is committed to fostering a transparent culture within which members of the University community are encouraged and feel supported in taking responsibility for seeking guidance and assistance in addressing accountability and compliance concerns.

The Office Provides Compliance Education and Investigative Services

Areas of Responsibility

Other Office Responsibilities and Information

Office History

In June 2012, UMB President Jay A. Perman, MD, created the Office of Accountability and charged it with building a Universitywide collaborative accountability framework that promotes and fosters a pervasive culture of accountability and transparency. Roger J. Ward, EdD, JD, MPA, was appointed as the University’s first Chief Accountability Officer.

Vision Statement

The University community embraces and perceives accountability and compliance as an essential management activity that leads to organizational improvement.

CAO Biography

Roger Ward

Roger J. Ward, EdD, JD, MPA

Chief Accountability Officer
Vice President, Operations and Planning

In June 2012, Dr. Ward was named the University of Maryland, Baltimore’s first chief accountability officer. Ward also is the University’s accreditation liaison officer for the Middle States Commission on Higher Education. Ward joined the University in March 2009 as associate vice president for academic affairs. In that role, he supported the former vice president for academic affairs in her role as chief academic affairs officer. Before joining UMB, Ward served as assistant vice president for student affairs at the New School in New York City and held senior administrative positions in the City University of New York system.

Ward holds an associate’s degree in data processing/computer programming from Kingsborough Community College, a bachelor’s degree in government and a master’s in public administration, both from John Jay College of Criminal Justice. He also holds a doctor of law degree from New York Law School and a doctor of education degree in higher education management from the University of Pennsylvania.

Policies and Reports

Our policies and procedures have been developed to ensure the safety and well-being of all members of the University community.

For Faculty

Universitywide Policies

Clery Report



Middle States Self-Study

Every 10 years, UMB undergoes a reaffirmation of its accreditation with the Middle States Commission on Higher Education (MSCHE). The process is an opportunity to strengthen the University through a comprehensive evaluation.

View the website for the Middle States Self-Study

Other Professional Accreditations

UMB has a very active cycle and culture of accreditation. Each professional school is accredited by a specialty accrediting body. In some schools, accreditation also happens at the program level.

View the list of professional school accreditations here

Student Right to Know

The AVP of Student Financial Assistance and Education is responsible for ensuring institutional compliance with Title IV regulations. This section provides students with information and transparency regarding UMB's efforts in financial aid, Title IX compliance, Higher Education Reauthorization Act compliance, Student Health and Safety, Student Outcomes, and Student Complaints and Grievances.

Go To Student Right to Know

Student Complaint Information

UMB participates in federal student aid programs that are authorized under Title IV of the Higher Education Act of 1965. Participating institutions must be legally authorized to operate with the state in which it is located.

Go To Student Complaint Information


FDA Guidance May 2020 - COVID-19: Developing Drugs and Biological Products for Treatment or Prevention

13 May 2020,  - The FDA is issuing this guidance to assist sponsors in the clinical development of drugs for the treatment or prevention of COVID-19. Click to read FDA guidance.

FDA Guidance May 2020 - COVID-19 Public Health Emergency: General Considerations for Pre-IND Meeting Requests for COVID-19 Related Drugs and Biological Products

13 May 2020,  - FDA is issuing this guidance to provide general considerations to assist sponsors in preparing pre-investigational new drug application (pre- IND) meeting requests for COVID-19 related drugs1 for the duration of the COVID-19 public health emergency. Click to read Pre-IND guidance.

New COVID-19 Research Involving Humans Information Section

11 May 2020, This section provides information on UMB’s Committees and Task Forces convened in response to the COVID-19 pandemic and human subjects research arising in response, the Biospecimen Repository being created under an umbrella protocol, COVID-19 Clinical and other Trials, and provides a FAQ for the research community.

2019 Ethics Week Celebration 

November 4th-9th, 2019

This is a time for organizations of all types and sizes to spotlight the efforts and actions that create and reinforce a culture of compliance.


President's Letter - Task Force on Sexual Harassment 

March 14th, 2019

Read UMB President's Mar. 2019 Letter to the Community announcing the assembly of Task Force.


UMB Notice: NIH Training Applications

March 7th, 2019

NIH Notice: NOT-OD-19-029 - Harassment and Discrimination Protections in NIH Training Applications.


How to Report Discrimination or Bias 

March 6th, 2019

Information and Contacts for reporting misconduct related to Discrimination or Bias.